annual ROE:
-219.59%-525.07%(-171.88%)Summary
- As of today (September 17, 2025), CDTX annual return on equity is -219.59%, with the most recent change of -525.07% (-171.88%) on December 31, 2024.
- During the last 3 years, CDTX annual ROE has risen by +43.46% (+16.52%).
- CDTX annual ROE is now -171.88% below its all-time high of 305.48%, reached on December 31, 2023.
Performance
CDTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-55.62%+118.23%(+68.01%)Summary
- As of today (September 17, 2025), CDTX quarterly return on equity is -55.62%, with the most recent change of +118.23% (+68.01%) on June 30, 2025.
- Over the past year, CDTX quarterly ROE has increased by +389.83% (+87.51%).
- CDTX quarterly ROE is now -74.63% below its all-time high of -31.85%, reached on June 30, 2015.
Performance
CDTX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CDTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -171.9% | +87.5% |
| 3 y3 years | +16.5% | +94.4% |
| 5 y5 years | -159.1% | +49.5% |
CDTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -171.9% | +76.7% | at high | +95.6% |
| 5 y | 5-year | -171.9% | +76.7% | at high | +95.6% |
| alltime | all time | -171.9% | +76.7% | -74.6% | +95.6% |
CDTX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -55.62%(-68.0%) |
| Mar 2025 | - | -173.85%(-21.6%) |
| Dec 2024 | -219.59%(-171.9%) | -221.80%(-19.6%) |
| Sep 2024 | - | -275.80%(-38.1%) |
| Jun 2024 | - | -445.45%(-17.8%) |
| Mar 2024 | - | -542.12%(+89.8%) |
| Dec 2023 | 305.48%(-132.4%) | -285.66%(+21.0%) |
| Sep 2023 | - | -236.07%(+148.8%) |
| Jun 2023 | - | -94.89%(-71.8%) |
| Mar 2023 | - | -336.96%(-73.1%) |
| Dec 2022 | -941.39%(+257.9%) | -1253.98%(+82.9%) |
| Sep 2022 | - | -685.59%(-31.3%) |
| Jun 2022 | - | -998.28%(+93.8%) |
| Mar 2022 | - | -515.04%(+13.3%) |
| Dec 2021 | -263.05%(-14.7%) | -454.40%(+4.9%) |
| Sep 2021 | - | -433.08%(+76.5%) |
| Jun 2021 | - | -245.41%(-11.2%) |
| Mar 2021 | - | -276.34%(+27.9%) |
| Dec 2020 | -308.44%(+263.9%) | -216.14%(+35.9%) |
| Sep 2020 | - | -159.05%(+44.5%) |
| Jun 2020 | - | -110.06%(+12.6%) |
| Mar 2020 | - | -97.77%(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -84.75%(-27.4%) | -93.73%(+19.3%) |
| Sep 2019 | - | -78.55%(-19.6%) |
| Jun 2019 | - | -97.73%(-13.5%) |
| Mar 2019 | - | -113.01%(+4.9%) |
| Dec 2018 | -116.66%(+54.8%) | -107.72%(-4.2%) |
| Sep 2018 | - | -112.40%(-0.8%) |
| Jun 2018 | - | -113.36%(+14.6%) |
| Mar 2018 | - | -98.96%(+19.2%) |
| Dec 2017 | -75.35%(+50.2%) | -82.99%(+2.4%) |
| Sep 2017 | - | -81.01%(+9.8%) |
| Jun 2017 | - | -73.75%(+19.1%) |
| Mar 2017 | - | -61.94%(+14.7%) |
| Dec 2016 | -50.15%(-2.6%) | -54.01%(+16.4%) |
| Sep 2016 | - | -46.39%(+18.3%) |
| Jun 2016 | - | -39.23%(+8.9%) |
| Mar 2016 | - | -36.01%(-7.1%) |
| Dec 2015 | -51.50%(-57.3%) | -38.75%(+11.9%) |
| Sep 2015 | - | -34.63%(+8.7%) |
| Jun 2015 | - | -31.85%(-30.7%) |
| Mar 2015 | - | -45.93%(-18.5%) |
| Dec 2014 | -120.72%(-225.6%) | -56.36% |
| Dec 2013 | 96.14% | - |
FAQ
- What is Cidara Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual ROE year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly ROE year-on-year change?
What is Cidara Therapeutics, Inc. annual return on equity?
The current annual ROE of CDTX is -219.59%
What is the all time high annual ROE for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual return on equity is 305.48%
What is Cidara Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, CDTX annual return on equity has changed by -525.07% (-171.88%)
What is Cidara Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of CDTX is -55.62%
What is the all time high quarterly ROE for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly return on equity is -31.85%
What is Cidara Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, CDTX quarterly return on equity has changed by +389.83% (+87.51%)